Month: January 2021 (Page 8)

Cannabis derivative manufacturer Valens Co. said it is liquidating most of its oil inventory, citing industry trends such as outdoor marijuana harvests and falling prices. Marijuana Business Daily has reported extensively on Canada’s glut of dried cannabis, edibles and extracts. The Toronto-headquartered company cited: An anticipated increase in outdoor cannabisContinue Reading

Marijuana retailers in Massachusetts filed a lawsuit against the state’s Cannabis Control Commission’s rules that allow only social equity applicants to deliver cannabis for the program’s first three years. Massachusetts cannabis retailers sue state over delivery regulations is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news forContinue Reading

As cannabis vaping pens grew in popularity in late 2019, concerns grew about the safety of the products, spurred by reports of illness, and even deaths, of tobacco vape users. Vape manufacturers rushed to assure regulators and consumers their products were safe, despite having no clear understanding of what ingredientsContinue Reading

Two of President-elect Joe Biden’s top picks to head the U.S. Department of Health and Human Services have track records of defending and supporting state-legal marijuana programs, positions that could prove positive for the overall MJ industry. Biden on Tuesday said he plans to nominate Pennsylvania Secretary of Health Dr.Continue Reading

Cannabis-related emergency department visits are thought to have more than tripled between 2011 and 2019, coincident with the legalization of recreational and medical cannabis in many US states. Yet there are no approved drugs to treat overdoses due to cannabis or synthetic cannabinoids like Spice and K2. IRISYS LLC, aContinue Reading

For years, word-of-mouth has pointed to the benefit of using cannabis to treat symptoms of post-traumatic stress disorder (PTSD). Yet, despite medical cannabis having been authorized by 24 US states for the treatment of PTSD, most doctors won’t prescribe it for their patients, citing a lack of epidemiological and clinicalContinue Reading